3 Boomerang Capital completed the investment in Bio-Response Solutions.

3 Boomerang Capital, a healthcare-focused, lower middle-market private equity firm, completed the investment in Bio-Response Solutions, a provider of sterilization and tissue digestion capital equipment. Financial terms were not disclosed. "We are excited to partner with Bio-Response and its leadership team as they continue to revolutionize the regulated medical waste management sector. Bio-Response's technology is uniquely positioned to address both consumer demand and regulatory shifts favoring sustainable cremation alternatives, making it an exciting investment for us," Peter Wen, 3 Boomerang Principal.